Starling Oncology, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Starling Oncology, Inc. (DFPH) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $3.63 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.63M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.97M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.04M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.31M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $3.63M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.97M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.04M 10-K · filed 2026-03-12 |
| 2025-09-30 | $4.31M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $4.61M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.75M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $5.18M 10-K · filed 2025-03-26 |
| 2024-09-30 | $5.63M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.76M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.03M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $6.52M 10-K · filed 2024-03-28 |
| 2023-09-30 | $6.41M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $6.70M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.35M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $4.17M 10-K · filed 2023-03-16 |
| 2022-09-30 | $4.40M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.26M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.17M 10-Q · filed 2022-05-10 |